HIV, inflammation, and initiation of methamphetamine use in sexual and gender minorities assigned male at birth
Carrico A, Ryan D, Berona J, Dominguez B, Schrock J, McDade T, Newcomb M, D’Aquila R, Mustanski B. HIV, inflammation, and initiation of methamphetamine use in sexual and gender minorities assigned male at birth. Proceedings Of The National Academy Of Sciences Of The United States Of America 2024, 121: e2407046121. PMID: 39348540, PMCID: PMC11474050, DOI: 10.1073/pnas.2407046121.Peer-Reviewed Original ResearchConceptsMethamphetamine useHIV diagnosisRate of incidenceRisk factorsHigh C-reactive proteinCox proportional-hazards modelC-reactive proteinPrevalence of methamphetamine useProportional-hazards modelSGM peopleIdentified risk factorsGender minoritiesInitiation of methamphetamine useHIV seroconversionInflammatory measuresPoisson regression analysisCohort studyHIVMethamphetaminePreventive interventionsBirthInflammationRegression analysisIncidenceDiagnosisHuman induced pluripotent stem cell-derived cardiomyocytes to study inflammation-induced aberrant calcium transient
Tatekoshi Y, Chen C, Shapiro J, Chang H, Blancard M, Lyra-Leite D, Burridge P, Feinstein M, D'Aquila R, Hsue P, Ardehali H. Human induced pluripotent stem cell-derived cardiomyocytes to study inflammation-induced aberrant calcium transient. ELife 2024, 13: rp95867. PMID: 39331464, PMCID: PMC11434618, DOI: 10.7554/elife.95867.Peer-Reviewed Original ResearchConceptsHuman induced pluripotent stem cell-derived cardiomyocytesPluripotent stem cell-derived cardiomyocytesStem cell-derived cardiomyocytesCell-derived cardiomyocytesUptake in vitroHIV viremiaDiastolic dysfunctionHIV patientsCardiomyocyte relaxationSarcoplasmic reticulumSGLT2 inhibitorsHeart failurePotential new interventionsInflammatory cytokinesAnimal modelsHFpEFStudy molecular mechanismsMito-TEMPOCardiomyocytesCytokinesHIVPatientsRelaxation defectsPLWHSerum
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply